Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveCamellia forecasts FY revenue of £255m to £260m

Live News EARNINGS FLASH M impact Oct 22, 2026, 06:36 AM UTC

Camellia forecasts FY revenue of £255m to £260m

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

CAM

Related stories

Fortune Motors Reports August Revenue of NT$2.47 Billion Fortune Motors' August revenue was NT$2,471,569,000, compared with NT$2,886,740,000 in 2025. January–August revenue was NT$23,781,090,000 versus NT$24,762,558,000. M impact | EARNINGS | Oct 22, 2026, 08:16 AM UTC Disco Corporation H1 Net Profit Rises to JPY80.366 Billion Disco Corporation reported first-half net profit of JPY80.366 billion, or JPY740.84 per share, compared with JPY55.913 billion and JPY515.70 per share a year earlier. M impact | EARNINGS | Oct 22, 2026, 08:15 AM UTC Nokia earnings above expectations at 0.09 EUR Nokia (NOKIA) released earnings per share at 0.09 EUR, compared to market expectations of 0.07 EUR. H impact | EARNINGS | Oct 22, 2026, 08:12 AM UTC argenx SE earnings above expectations at 6.95 USD argenx SE (ARGX) released earnings per share at 6.95 USD, compared to market expectations of 6.14 USD. H impact | EARNINGS | Oct 22, 2026, 08:12 AM UTC Skandinaviska Enskilda Banken earnings below expectations at 3.81 SEK Skandinaviska Enskilda Banken (SEBA) released earnings per share at 3.81 SEK, compared to market expectations of 4.03 SEK. H impact | EARNINGS | Oct 22, 2026, 08:12 AM UTC UCB Raises Annual Guidance for Second Time This Year; Shares Jump 13% UCB cited strong U.S. demand for its Bimzelx drug as it raised annual guidance for the second time this year. Shares rose 13% in European morning trading, erasing year-to-date loss M impact | EARNINGS | Oct 22, 2026, 08:10 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.